IR Event on CartiLife China Entry and Global Pipeline Clinical Updates
-
IR held on May 7, 2026 via online conference call for domestic institutional investors -
Key topics: CartiLife China market entry strategy and global key pipeline clinical progress and commercialization strategy
KOSDAQ Filing Information
- Filing: Holding of Investor Relations Conference (IR)
- Company: Bio Solution (086820)
- Submission: Bio Solution Co.,Ltd.
- Receipt: 04-29-2026
- Under KRX KOSDAQ Market Division